Use of Ursodeoxycholic Acid and Cancer Risk for Patients With Primary Biliary Cholangitis

This cohort study uses electronic health record data to compare cancer incidence among adults with primary biliary cholangitis who were or were not treated with ursodeoxycholic acid (UDCA).

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-12-19
DOI
https://doi.org/10.1001/jamanetworkopen.2025.50907
Citations
1
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of Ursodeoxycholic Acid and Cancer Risk for Patients With Primary Biliary Cholangitis

Parth Jagrut Patel, Lyra Su, Xiang Shu
1 citations
JAMA Network Open
Liver Diseases and Immunity
1.32
article

Use of Ursodeoxycholic Acid and Cancer Risk for Patients With Primary Biliary Cholangitis

Parth Jagrut Patel, Lyra Su, Xiang Shu
article en
1 citations

Abstract

This cohort study uses electronic health record data to compare cancer incidence among adults with primary biliary cholangitis who were or were not treated with ursodeoxycholic acid (UDCA).

JAMA Network OpenVol. 8(12)
Memorial Sloan Kettering Cancer Center (US), Rowan University (US)
Openalex Percentile: Top 14%
Liver Diseases and Immunity
1.32
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.